FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to the use of oxalate (Z)-O-(2-morpholinoethyl)oxime of 4-benzoylpyridine (“ГИЖ-298”) as an analgesic agent.
EFFECT: wider range of analgesic agents, including effective in somatic, visceral pain, and affecting the spinal flexor reflex, and the possibility of using “ГИЖ-298” as an analgesic and in patients suffering from convulsive syndromes, which are a contraindication for the use of certain analgesics.
1 cl, 6 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN GEL MEDICINAL FORM FOR LOCAL USE ON THE BASIS OF N-(2-ADAMANTIL)-HEXAMETHYLENEMINE HYDROCHLORIDE | 2017 |
|
RU2663452C1 |
AGENT WITH PROLONGED ANALGESIC ACTION AND MEDICINAL PRODUCT BASED THEREON | 2020 |
|
RU2755206C1 |
QUINAZOLIN-4(3H)-ONE DIMETHOXYBENZYLSULFO DERIVATIVE WITH ANALGESIC, ANTIPARKINSONIAN, ANXIOLYTIC, PSYCHOSTIMULATING ACTIVITY | 2021 |
|
RU2758333C1 |
PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
2-BENZYL DERIVATIVE OF 4-(3H)QUINAZOLINONE, HAVING ANALGESIC, ANTI-PARKINSONIAN, ANTIHYPOXANT, TRANQUILISING ACTION | 2019 |
|
RU2715884C1 |
NOVEL EFFICIENT INHIBITOR OF KINASE 4, ASSOCIATED WITH INTERLEUKIN-1 (IRAK4) | 2015 |
|
RU2613973C1 |
4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
AMINOALKYL DERIVATIVES OF DIBENZOFURANONE OXIME EXHIBITING ANTICONVULSANT ACTIVITY | 2020 |
|
RU2773021C2 |
PREPARATION OF ANTIPAIN WITH ACTIVITY AND CAPACITY TO RAISE HIGHER POWER OF ANALGETICS ACTION | 2001 |
|
RU2183957C1 |
WATER-SOLUBLE TYROSINE DERIVATIVES HAVING ANALGESIC, ANTI-INFLAMMATORY AND ANTIEDEMIC ACTION | 2017 |
|
RU2678563C1 |
Authors
Dates
2024-10-15—Published
2024-02-20—Filed